These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 241148

  • 1. [Metoprolol, a new cardioselective beta blocking agent in the treatment of arterial hypertension].
    Pedersen OL.
    Ugeskr Laeger; 1975 Sep 22; 137(39):2274-6. PubMed ID: 241148
    [No Abstract] [Full Text] [Related]

  • 2. Hypotensive action of ICI66.082, a new beta-adrenergic blocking agent.
    Hansson L, Henningsen NC, Karlberg B, Aberg H, Jameson S, Malmcrona R, Hersvall C.
    Int J Clin Pharmacol; 1974 Oct 22; 10(3):206-11. PubMed ID: 4154313
    [No Abstract] [Full Text] [Related]

  • 3. Studies with a new cardioselective beta-blocker, metoprolol.
    Werkö L, Aurell M, Johnsson G, Sannerstedt R, Svedmyr N.
    Adv Clin Pharmacol; 1976 Oct 22; 11():19-25. PubMed ID: 1032569
    [Abstract] [Full Text] [Related]

  • 4. [Efficacy and tolerability of tertatolol in the treatment of mild to moderate arterial hypertension. Results of a French multicenter study with 2,338 patients treated over one year].
    Herpin D, Piron J, Bajou B, Lecasble M.
    Ann Cardiol Angeiol (Paris); 1989 Oct 22; 38(8):503-7. PubMed ID: 2574560
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical evaluation of betaxolol (Kerlone) as a once-daily treatment for hypertension in 4685 patients.
    Djian J.
    Br J Clin Pract; 1985 May 22; 39(5):188-91. PubMed ID: 2866790
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long term non-selective and cardioselective beta-receptor blockade in hypertensive patients. Effects on circulatory parameters, catecholamines and renin activity under basal conditions and in connection with exercise and hypoglycemia.
    Hansson BG.
    Acta Med Scand Suppl; 1976 May 22; 598():1-61. PubMed ID: 13611
    [No Abstract] [Full Text] [Related]

  • 11. Phase III long-term study and comparative clinical study of nipradilol ophthalmic solution in patients with primary open-angle glaucoma and ocular hypertension. Part 2.
    Kanno M, Araie M, Masuda K, Takase M, Kitazawa Y, Shiose Y, Azuma I, Ogawa N, Ohdo S.
    Arzneimittelforschung; 2006 May 22; 56(12):820-5. PubMed ID: 17260669
    [No Abstract] [Full Text] [Related]

  • 12. Clinical evaluation of bevantolol hydrochloride in patients with severe hypertension. The Cooperative Study Group on Bevantolol in Japan.
    Noshiro T, Miura Y, Yoshinaga K, Iimura O, Inagaki Y, Saruta T, Ishii M, Yamazaki N, Arakawa K.
    Int J Clin Pharmacol Ther; 1995 Apr 22; 33(4):240-5. PubMed ID: 7620695
    [Abstract] [Full Text] [Related]

  • 13. Nadolol, a once daily treatment for hypertension: multi-centre clinical evaluation.
    Jackson DA.
    Br J Clin Pract; 1980 Jul 22; 34(7):211-21. PubMed ID: 6107120
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The antihypertensive effect of a new beta-adrenergic blocking drug metroprolol in combination with chlorthalidone].
    Jäättelä A, Pyöräiä K.
    Duodecim; 1976 Jul 22; 92(11):597-603. PubMed ID: 7445
    [No Abstract] [Full Text] [Related]

  • 16. [Hemodynamics of hypertension. Changes caused by beta-blocking agents].
    Mattioli G, Ricci S, Bertoncelli P.
    Minerva Cardioangiol; 1979 Jul 22; 27(7-8):463-72. PubMed ID: 44898
    [No Abstract] [Full Text] [Related]

  • 17. [A comparative evaluation of metoprolol and methyldopa in hypertension therapy (author's transl)].
    Muiesan G, Agabiti-Rosei E, Buoninconti R, Carotti A, Fariello R, Innocenti P, Solinas E, Toso M, Motolese M.
    G Ital Cardiol; 1980 Jul 22; 10(11):1482-90. PubMed ID: 7202896
    [Abstract] [Full Text] [Related]

  • 18. Initial clinical experience with I.C.I. 66.082, a new beta-adrenergic blocking agent, in hypertension.
    Hansson L, Aberg H, Jameson S, Karlberg B, Malmcrona R.
    Acta Med Scand; 1973 Dec 22; 194(6):549-50. PubMed ID: 4149321
    [No Abstract] [Full Text] [Related]

  • 19. Beta-adrenergic blocking therapy in hypertension: selection of patients.
    Frohlich ED, Tarazi RC, Dustan HP.
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec 22; 4(1):151-6. PubMed ID: 4395481
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.